Overcoming Ovarian Cancer Chemoresistance (Volume 11) (Cancer Sensitizing Agents for Chemotherapy, Volume 11) - Image 1

£108.21

Academic Press Overcoming Ovarian Cancer Chemoresistance (Volume 11) (Cancer Sensitizing Agents for Chemotherapy, Volume 11)

Name: Overcoming Ovarian Cancer Chemoresistance (Volume 11) (Cancer Sensitizing Agents for Chemotherapy, Volume 11)
Brand: Academic Press
Price: 108.21 GBP
Availability: InStock

Oncology

This is the usual price. Wait for it to drop, or tell us your number.

£108 today · usual range £0–£0 · best ever £102

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 638 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £106-110 (428 days, 67.1%)

Price range: £102 - £123

Price levels: 5 price ranges over 638 days

Description

Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment. The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future. This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer. Review The latest information on precision medicine approaches for women with ovarian cancer About the Author Dr Samimi currently serves as a Program Director in the Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, NCI. She manages the Ovarian Cancer Prevention portfolio and scientific monitoring of early phase ovarian cancer clinical trials within the NCI Division of Cancer Prevention Early Phase Prevention Consortia. Dr. Samimi’s research interests include molecular mechanisms of ovarian cancer etiology, circulating/shed DNA as a biomarker of ovarian cancer, and improving identification of high-risk individuals including BRCA1/2 mutation carriers. Dr. Samimi currently serves on the Trans-NCI Cancer and Bioethics Working Group, and the NCI Moonshot Generation of Human Tumor Atlases Implementation Team. Dr Annunziata is Principal Investigator and Clinical Director of the Women’s Malignancies Branch at the National Cancer Institute in Bethesda, Maryland. She received her MD and PhD from Georgetown University, and completed residency in Internal Medicine at that institution, followed by Medical Oncology Fellowship at the NCI. In the Intramural Program of the NCI, she runs a translational research laboratory and is involved with several clinical protocols. She has mentored both scientific and clinical fellows, who moved on to Assistant Professor positions, with independent grant funding. Outside the NIH, Dr. Annunziata has chaired grant review committees for ASCO and DOD.

Product Specifications

Brand: Academic Press
Format: Hardcover
ASIN: 0128198400
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 14 November 2020
Listed Since: 01 October 2019

Barcode

No barcode data available

Academic Press Overcoming Ovarian Cancer Chemoresistance (Volume 11) (Cancer Sensitizing Agents for Chemotherapy, Volume 11)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Advances in Diagnosis and Management of Ovarian Cancer

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

The Tumor Microenvironment of High Grade Serous Ovarian Cancer

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Etiology of Breast and Gynecological Cancers (Progress in Clinical and Biological Research)

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Gynecologic Radiation Oncology: A Practical Guide

Springer Uterine Cancer: Screening, Diagnosis, and Treatment

DiSaia and Creasman Clinical Gynecologic Oncology

Fundamentals in Gynaecologic Malignancy

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Gender and Cancer in England, 1860-1948 (Medicine and Biomedical Sciences in Modern History)

Clinical Cancer Prevention: 188 (Recent Results in Cancer Research, 188)

Translational Advances in Gynecologic Cancers

Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)

Precision Medicine in Gynecology and Obstetrics (Comprehensive Gynecology and Obstetrics)

Hereditary Gynecologic Cancer: Risk, Prevention and Management

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Atlas of Clear Cell Carcinoma of the Ovary: A Pathological Guide

Ovarian Cancer: 23 (Cancer Treatment and Research, 23)

Pathology of Female Cancers: Precursor and Early-Stage Breast, Ovarian and Uterine Carcinomas

Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)